As pharmaceutical and health-care companies worldwide battle to meet increasing demand for surgical masks in the midst of global shortages, a potentially lucrative secondary market has cropped up, resulting in prices skyrocketing.

Surgical masks have become the go-to protection against the coronavirus, which has so far killed more than 2,000 people, according to the World Health Organisation - and as the death toll rises, so does the global demand for masks.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now